Suppr超能文献

单发直径不超过 5 厘米的肝细胞癌行肝切除术后米兰标准以外复发的危险因素。

Risk Factors for Beyond Milan Recurrence After Hepatic Resection for Single Hepatocellular Carcinoma No Larger Than 5 Centimeters.

机构信息

Department of Liver Transplantation and Hepatobiliary Surgery Ajou University School of Medicine Suwon Korea Clinical Trial Center Ajou University School of Medicine Suwon Korea.

出版信息

Liver Transpl. 2021 Aug;27(8):1116-1129. doi: 10.1002/lt.26070. Epub 2021 Jul 14.

Abstract

Hepatic resection (HR) is considered a treatment of choice for a single hepatocellular carcinoma (HCC) ≤5 cm in patients with preserved liver function. However, it is possible for these patients to develop a severe form of recurrence (beyond Milan recurrence [BMR] criteria). This recurrence could have been avoided if liver transplantation (LT) was performed primarily, as LT is believed to yield a more favorable oncological outcome compared with HR. The aim of this study was to determine the risk factors for BMR after HR and to verify whether primary LT can provide a more favorable outcome in patients with BMR risk factors. Data from 493 patients who underwent HR for HCC ≤5 cm between 1995 and 2016 were analyzed. Among them, 74 patients (15%) experienced BMR. The 10-year survival rate of patients with BMR was significantly low compared with that of patients without BMR (22.6% versus 79.8%; P < 0.01). In multivariate analysis, calculated hepatic venous pressure gradient ≥7 mm Hg and microvascular invasion were identified as the risk factors for BMR (P < 0.05). During the same period, 63 eligible patients underwent LT as a primary treatment for HCC ≤5 cm. No significant difference in long-term survival rate was observed when no risk factor for BMR was present in the HR and LT groups (85.5% versus 100%; P = 0.39). However, 10-year survival was poorer in the HR group in the presence of risk factors for BMR (60.6% versus 91.8%; P < 0.001). Among the patients with HCCs ≤5 cm, which are resectable and transplantable, LT is indicated when calculated hepatic venous pressure gradient ≥7 mm Hg and/or microvascular invasion is present.

摘要

肝切除术(HR)被认为是肝功能正常的单个肝细胞癌(HCC)≤5cm 患者的首选治疗方法。然而,这些患者可能会出现严重的复发形式(超出米兰复发[BMR]标准)。如果最初进行肝移植(LT),这种复发是可以避免的,因为与 HR 相比,LT 被认为能获得更好的肿瘤学结果。本研究旨在确定 HR 后 BMR 的危险因素,并验证原发性 LT 是否能为具有 BMR 危险因素的患者提供更好的结果。分析了 1995 年至 2016 年间 493 例接受 HCC≤5cm HR 的患者的数据。其中,74 例(15%)发生 BMR。与无 BMR 的患者相比,BMR 患者的 10 年生存率显著降低(22.6%比 79.8%;P<0.01)。多变量分析显示,计算的肝静脉压力梯度≥7mmHg 和微血管侵犯是 BMR 的危险因素(P<0.05)。同期,63 例符合条件的患者因 HCC≤5cm 行 LT 作为原发性治疗。在 HR 和 LT 组均无 BMR 危险因素的情况下,两组的长期生存率无显著差异(85.5%比 100%;P=0.39)。然而,在 HR 组存在 BMR 危险因素时,10 年生存率较差(60.6%比 91.8%;P<0.001)。在可切除和可移植的 HCC≤5cm 患者中,当计算的肝静脉压力梯度≥7mmHg 和/或存在微血管侵犯时,应进行 LT。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验